Well Told Grants

Federal grant recipients / Indiana

Federal grants to Medosome Biotec LLC

Bloomington, Indiana · Small businesses · UEI MJJJFTJE1SB5

Medosome Biotec LLC in Bloomington, Indiana received $7.0 million in federal grants from fiscal 2021 to 2025, across 8 awards. Its largest program was Child Health and Human Development Extramural Research, with $2.7 million. It had no new grant money in fiscal 2025.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Medosome Biotec LLC by fiscal year
Fiscal yearAwardsAmount
FY 20213$2.5 million
FY 20225$2.8 million
FY 20232$1.3 million
FY 20241$350,000
FY 20250$0

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Medosome Biotec LLC

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Child Health and Human Development Extramural Research 93.8653$2.7 million
Allergy and Infectious Diseases Research 93.8551$2.0 million
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8472$1.6 million
Biomedical Research and Research Training 93.8591$350,000
National Center for Advancing Translational Sciences 93.3501$325,000

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services8$7.0 million

Largest awards

The 8 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
A method for accurate and sensitive detection of HIV drug-resistant minority variants - project summary / abstract drug resistance to HIV is a major threat to achieving long-term viral suppression in HIV+ individuals. Up to 16% of newly infected individuals acquire HIV with resistance to at least on
ASST_NON_R42AI122855_075 on USAspending
Allergy and Infectious Diseases ResearchJuly 19, 2022$2.0 million
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
ASST_NON_R42HD089804_075 on USAspending
Child Health and Human Development Extramural ResearchJune 14, 2021$2.0 million
Next generation quantitative hcv drug resistance assay - project summary / abstract the objective of this phase II application is to complete the development of a next generation quantitative drug resistance linkage assay that can accurately determine the abundance and linkage of hcv variants resist
ASST_NON_R44DK112540_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchJuly 19, 2021$1.6 million
Prevention of white matter injury in premature infants
ASST_NON_R42HD097911_075 on USAspending
Child Health and Human Development Extramural ResearchMay 20, 2021$700,593
Metabolism and mitochondrial energetics therapy for septic shock - project summary / abstract metabolic reprogramming plays a critical role in immune cell activation, differentiation, and function in response to severe sepsis. Broad defects in leukocyte bioenergetics underlie the immunometabolic par
ASST_NON_R42GM151928_075 on USAspending
Biomedical Research and Research TrainingSeptember 12, 2024$350,000
Engineering next generation probiotics for delivery of therapeutics - project summary / abstract peptide and protein drugs (PPDS) are potent therapeutics to treat a broad spectrum of diseases. Parenteral administration is limited due to their poor bioavailability and stability. Oral delivery of ppds
ASST_NON_R43TR004525_075 on USAspending
National Center for Advancing Translational SciencesJuly 27, 2023$325,000
Next generation quantitative hcv drug resistance assay
ASST_NON_R43DK112540_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchSeptember 26, 2022$15,206
Development of casr nutrient therapy for childhood diarrhea
ASST_NON_R41HD092133_075 on USAspending
Child Health and Human Development Extramural ResearchSeptember 26, 2022$14,648

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Medosome Biotec LLC get?

$7.0 million in 8 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Medosome Biotec LLC the most?

The Department of Health and Human Services, with $7.0 million in 8 awards.

What is Medosome Biotec LLC's largest federal grant?

$2.0 million under Allergy and Infectious Diseases Research, with its first action in the period on July 19, 2022. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Medosome Biotec LLC?

Its largest are Child Health and Human Development Extramural Research, Allergy and Infectious Diseases Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.

Other grant recipients in Bloomington

Largest federal grant recipients in Indiana · Federal grants in Indiana